An opportunity to invest in world-leading cancer research at the Beatson
Professor Anthony Chalmers, Clinical Oncology Institute of Cancer Sciences & Beatson West of Scotland Cancer Centre University of Glasgow
“For many years, radiotherapy has been one of the most effective forms of cancer treatment. A half of all patients receive it, while it’s the primary form of treatment for two-fifths of patients whose cancer is cured. However, the potential damage to surrounding, healthy cells means that we have to limit the amount of treatment we can give to patients. All that, however, is about to change.
“Over the last five to ten years, there’s been a revolution in radiotherapy technology. Today, we have a wide range of innovative tools and approaches that deliver radiotherapy much more accurately (see opposite). It means that, in some cases, we can give a higher dose. In other cases, where we can’t increase the dose, we can combine it with innovative drugs to make it more effective against cancer.
“These are exciting breakthroughs, and at The Beatson we’re continuing to refine and improve them in the laboratory. But the next critical step is to test them in patients. And for that, we need your support to create the Radiotherapy Research Project.
“Many of the new drugs that are revolutionising radiotherapy technology have been developed right here in Glasgow. Now we need to put in place the experts who will turn pioneering research into life-saving cancer treatment in patients.
“We hope to significantly increase the chances of treatments shrinking and controlling tumours. This, in turn, will lead to increased survival rates in cancers where there is a poor outlook, such as those of the lung, brain, pancreas, head and neck. In short, more people will win the battle against cancer.”
Three major advances we aim to test in patients:
- Intensity Modulated Radiotherapy
This lets us deliver radiotherapy much more accurately to cancers that are irregular in shape or close to critical structures like the spinal cord or heart.
- Image Guided Radiotherapy
Using sophisticated MRI or PET-scanning techniques, we can track cancers as they move or change in shape or size during cancer treatment.
- Molecular targeted agents
These new-generation drugs can be combined with radiotherapy to knock out specific molecules that are resistant to cancer treatments.
Andrew Fairlie, Chef Patron, Restaurant Andrew Fairlie, The Gleneagles Hotel tells us why he's backing the Radiotherapy Research Project.
“Like thousands of other Scots, I was devastated when I was told I had cancer.
“Fortunately, I was in the best of hands at the Beatson West of Scotland Cancer Centre.
“It was during my radiotherapy treatment that I met Professor Anthony Chalmers. When he told me about his ambitious plans for the Radiotherapy Research Project, I knew I had to get involved. To have world-leading research right here in Scotland, giving patients the very best chance of beating cancer, is a truly amazing opportunity. We simply must grasp it.
“What we fund now could change the nature of cancer treatment, not just for my family or yours, but for generations to come. It’s incredible to think that, together, we could set up the research that means more people across Scotland – and the world – win the fight against cancer.”
To show your support to the Radiotherapy Research Project please visit here to donate. Thank you.